UTAH MEDICAL PRODUCTS, INC. Contractual Obligation
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Contractual Obligation of $4.34 million as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:ContractualObligation · last filed 2026-03-27
- 2025-12-31: Contractual Obligation $4.34M.
- 2024-12-31: Contractual Obligation $3.75M.
- 2023-12-31: Contractual Obligation $4.53M.
- 2022-12-31: Contractual Obligation $5.24M.
| Period end | Contractual Obligation |
|---|---|
| 2025-12-31 | $4.34M 10-K · filed 2026-03-27 |
| 2024-12-31 | $3.75M 10-K · filed 2025-03-26 |
| 2023-12-31 | $4.53M 10-K · filed 2024-03-26 |
| 2022-12-31 | $5.24M 10-K/A · filed 2023-03-28 |
| 2021-12-31 | $4.89M 10-K · filed 2022-03-25 |
| 2020-12-31 | $3.29M 10-K · filed 2021-03-26 |
| 2019-12-31 | $3.06M 10-K · filed 2020-03-16 |
| 2018-12-31 | $1.64M 10-K · filed 2019-03-14 |
| 2017-12-31 | $2.19M 10-K · filed 2018-03-06 |
| 2016-12-31 | $2.52M 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |